Search results
3 big changes coming to Medicare in 2025—and what they’ll mean for you
Fortune via Yahoo Finance· 2 days agoThe advice for people looking to enroll in Medicare Part D plans in 2025: Review your choices...
3.6 million Medicare recipients could qualify for Wegovy under new rule - UPI.com
UPI· 20 minutes agoThe U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the...
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
WISN 12 Milwaukee· 5 hours agoAbout 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy,...
Wegovy could soon treat millions of Medicare patients
Quartz· 4 hours agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
Millions of Medicare recipients could gain access to weight-loss drug
Newsweek· 6 hours agoMillions of overweight or obese patients with heart conditions insured under Medicare could gain...
Untangling The Multiple Parts Of Medicare : 1A
NPR· 1 hour agoAnd then there's Medicare Advantage. Unlike traditional Medicare, which is through the government, Medicare Advantage is a privatized ...
6 Medicare mistakes to avoid if you’re working past age 65
Bankrate via Yahoo Finance· 5 days agoHere’s how to avoid easy mistakes while navigating your new health insurance options. 1. Not taking...
Analyst Report: Humana Inc.
Morningstar Research via Yahoo Finance· 2 hours agoHumana is one of the largest private health insurers in the US with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored ...
Medicare, SSA mistake leaves stage 4 cancer patient without insurance coverage
WCNC Charlotte· 3 hours agoTo a stranger, Pam Ellis still radiates. Ellis spends most of the day sleeping, has lost a third of...
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Reuters· 4 hours agoWegovy was approved by the U.S. health regulator last month for lowering the risk of stroke and...
